ATRX and glioblastoma: ATRX mutation was observed in 4.4% (15/343) of GBM-IDHwt patients, and its frequency in A-IDHm grade 2, grade 3, and grade 4 was 69.2% (9/13), 78.6% (33/42), and 70.3% (26/37), respectively.